Global prevalence and risk factors of osteoporosis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
Globale Prävalenz und Risikofaktoren von Osteoporose bei Patient:innen mit chronisch obstruktiver Lungenerkrankung: systematische Übersichtsarbeit und Metaanalyse
BMC Public Health · 19.08.2026 · 26 (1)
DOI: 10.1186/s12889-026-28811-1 ↗Auf einen Blick
Die Metaanalyse zeigt bei Patient:innen mit COPD eine gepoolte Osteoporose-Prävalenz von 33,8 %. Untergewicht, Kortikosteroide und geringere Lungenfunktion waren mit Osteoporose assoziiert.
Fragestellung
Wie häufig ist Osteoporose bei COPD, und welche klinischen Faktoren sind damit assoziiert?
Methode
Systematische Übersicht und Metaanalyse beobachtender Studien; Suche in EMBASE, CINAHL, Scopus, PubMed und Cochrane Library bis 5. Februar 2026; Random-effects-Modelle, Subgruppenanalysen, Sensitivitätsanalysen und Meta-Regression.
Ergebnisse
87 Studien mit 1.453.879 Patient:innen. Prävalenz 33,8 % (95 %-KI 31,4–36,1), I²=99,7 %. Untergewicht: OR 3,91 (95 %-KI 1,36–11,24); Kortikosteroide: OR 2,85 (95 %-KI 1,45–5,59); FEV₁%: OR 0,97 (95 %-KI 0,96–0,98).
Einschränkungen
Extrem hohe Heterogenität, Unterschiede in der Kovariatenanpassung und begrenzte Evidenz für einige Subgruppenanalysen.
Schlussfolgerung der Autor:innen
Osteoporose betrifft in den eingeschlossenen Studien etwa ein Drittel der COPD-Patient:innen. Die Autor:innen raten wegen der Heterogenität und begrenzten Evidenz zu vorsichtiger Interpretation.
Kernaussagen
- Prävalenz von Osteoporose bei COPD: 33,8 %
- Untergewicht und Kortikosteroide waren mit höherer Osteoporose-Rate verbunden
- Höheres FEV₁% war mit geringeren Odds für Osteoporose assoziiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift BMC Public Health, online erschienen am 19.08.2026. Verfasst von Chunhui Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Osteoporosis, Global Health. Die Arbeit nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Background
Osteoporosis (OP) is a common comorbidity in patients with chronic obstructive pulmonary disease (COPD), but reported prevalence estimates vary substantially across studies, and the magnitudes of associations between OP and potentially modifiable factors remain uncertain. This systematic review and meta-analysis aimed to provide an updated estimate of the prevalence of OP among patients with COPD, explore potential sources of heterogeneity, and synthesise adjusted associations with selected clinical factors.
Methods
EMBASE, CINAHL, Scopus, PubMed, and the Cochrane Library were searched from inception to 5 February 2026. Only observational studies published in English involving adults with objectively diagnosed COPD and reporting OP prevalence or associated factors were included. Two reviewers independently conducted study selection, data extraction, and quality assessment using the Newcastle–Ottawa Scale or the AHRQ assessment tool. Random-effects models were used for all quantitative syntheses. Risk-factor analyses were based exclusively on adjusted ORs. Subgroup analyses, leave-one-out sensitivity analyses, and univariable meta-regression were used to explore heterogeneity.
Results
Eighty-seven studies involving 1,453,879 patients with COPD were included. The pooled prevalence of OP was 33.8% (95% CI 31.4%–36.1%), with extremely high between-study heterogeneity (I²=99.7%). Prevalence estimates varied geographically, ranging from 28.7% in Europe and 28.8% in Africa to 42.3% in North America. The methodological quality score was significantly associated with variation in prevalence estimates in univariable meta-regression ( P < 0.001), although substantial residual heterogeneity remained. Underweight was associated with higher odds of OP (OR = 3.91, 95% CI 1.36–11.24). Corticosteroid exposure was also associated with OP (OR = 2.85, 95% CI 1.45–5.59). In an exploratory analysis based on two studies involving 172 participants, cumulative systemic corticosteroid exposure exceeding 1,000 mg prednisone-equivalent was associated with higher odds of OP (OR = 7.36, 95% CI 1.70–31.98). Higher FEV₁% predicted was associated with lower odds of OP (OR = 0.97, 95% CI 0.96–0.98). No statistically significant associations were identified for age ≥ 65 years or overweight status.
Conclusions
OP affects approximately one-third of patients with COPD across the included studies. Underweight, corticosteroid exposure, and reduced lung function were associated with OP, but the findings should be interpreted cautiously because of extreme residual heterogeneity, differences in covariate adjustment, and limited evidence available for some subgroup analyses. Standardised diagnostic methods and better reporting of clinical, treatment-related, and sociodemographic characteristics are needed to improve future risk estimation. PROSPERO registration number CRD420261381268.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China.
- The Third Department of Pulmonary Diseases, The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China.
- The Third Department of Orthopedics, The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China.
- Second Department of Gastroenterology, Northeast International Hospital Houde Campus, Shenyang, Liaoning Province, China.
- The Center for Preventive Treatment of Disease, The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China.
- College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, Hunan Province, China. jilisch@163.com.
Zitieren
APA
Yu, C., Teng, X., Du, W., Ma, X., Yu, C., Xia, Y., Hui, J., Xie, F., Li, J., & Hu, S. (2026). Global prevalence and risk factors of osteoporosis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Public Health, 26(1). https://doi.org/10.1186/s12889-026-28811-1
Vancouver
Yu C, Teng X, Du W, Ma X, Yu C, Xia Y, et al. Global prevalence and risk factors of osteoporosis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Public Health. 2026;26(1). doi:10.1186/s12889-026-28811-1
BibTeX
@article{Yu2026,
author = {Yu, Chunhui and Teng, Xuejiao and Du, Weilong and Ma, Xilan and Yu, Chunhao and Xia, Yunfeng and Hui, Jipeng and Xie, Fei and Li, Ji and Hu, Shilong},
title = {Global prevalence and risk factors of osteoporosis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis},
journal = {BMC Public Health},
year = {2026},
volume = {26},
number = {1},
doi = {10.1186/s12889-026-28811-1}
}
EUVIMED